Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks (2024)
Fonte: Ageing Research Reviews. Unidade: FCF
Assuntos: DEGENERAÇÃO MACULAR, NANOPARTÍCULAS, CÉLULAS-TRONCO, ENSAIO CLÍNICO
ABNT
KUMBHAR, Popat et al. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks. Ageing Research Reviews, v. 98, p. 1-20 art. 102322, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102322. Acesso em: 09 nov. 2024.APA
Kumbhar, P., Kolekar, K., Vishwas, S., Shetti, P., Kumbar, V., Pinto, T. de J. A., et al. (2024). Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks. Ageing Research Reviews, 98, 1-20 art. 102322. doi:10.1016/j.arr.2024.102322NLM
Kumbhar P, Kolekar K, Vishwas S, Shetti P, Kumbar V, Pinto T de JA, Santos ACP, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks [Internet]. Ageing Research Reviews. 2024 ; 98 1-20 art. 102322.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102322Vancouver
Kumbhar P, Kolekar K, Vishwas S, Shetti P, Kumbar V, Pinto T de JA, Santos ACP, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks [Internet]. Ageing Research Reviews. 2024 ; 98 1-20 art. 102322.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102322